ADAPT’s Citizens’ Think-Ins Knowledge Sharing Forum Recording
ADAPT hosted a virtual knowledge-sharing forum online on 7 September to explore the outcomes and insights generated by the 2021/2022 Citizens’ Think-In series.
At the event, we heard from participating researchers, our community and evaluation partners. We shared tips for hosting your own Think-In in order to stimulate citizen-researcher conversations on STEM research and innovation.
About the Speakers
Dr Patricia Scanlon is Ireland’s first AI Ambassador and is the founder and CEO of Soapbox Labs. As AI Ambassador, Patricia will lead a national conversation on the role of AI in our lives, its benefits, and how Irish enterprises can embrace AI-powered technologies. A key part of the ambassador’s role is to promote an ethical approach to AI that puts humans first.
Dr P.J. Wall is Research Fellow and Teaching Fellow with the School of Computer Science in Trinity College Dublin. His main research interests are AI ethics and the potential of advanced technology to reconfigure practice in healthcare and education. He is particularly interested in the social, cultural, and political aspects of the development, implementation and use of such technologies in low-resource contexts. His previous work has examined technological innovation in the Global South (Sierra Leone) with a focus on the use of mobile devices/apps, and the ethical implications associated with using such technology in this context.
Professor Eric Jensen is a social scientist with extensive methodological expertise in quantitative, qualitative and mixed methods social research and evaluation. Jensen has been working in science communication research and practice since 2001.
Robert Joyce is a blogger (www.A30MinuteLife.com) where he shares how he lives with chronic illness (multiple sclerosis, chronic pain, asthma & sarcoidosis). Since starting his blog, he has become active as a Patient Advocate, advising public and private organisations on how to include the patient and public in their activities. He has also been an Embedded Patient Researcher on the award winning COB-MS (www.cob-ms.com) feasibility trial, a new cognitive therapy for people living with MS.
Professor Mark Little is a clinician scientist with an interest in translational immunology as applied to autoimmune disease. He links a cellular immunology lab in Trinity Translational Medicine Institute to the Chronic Disease Informatics Group in the ADAPT Centre with the goal of creating deep phenotyping platforms and predictive analytic tools to improve patient care.
